Strumento inattivo

Altre lingue Lotus Pharmaceuticals, Inc. Other OTC

Azioni

LTUS

US5457152032

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Lotus Achieves Historic Q3 2023 Results with YTD EPS Soaring to a Record NTD 14.19 Marking a 29% Year-on-Year Growth	10/11
Lotus Continued Stelar Growth in 2Q 2023 EPS Recorded NTD 4.85 with 285% Growth Year on Year	12/09/23
Lotus Continued Stelar Growth in 2Q 2023 EPS Recorded NTD 4.85 with 285% Growth Year on Year	14/08/23
AMARIN AND LOTUS PHARMACEUTICALS ANNOUNCE EXCLUSIVE PARTNERSHIP AGREEMENT TO COMMERCIALIZE VAZKEPA IN SOUTHEAST ASIA AND SOUTH KOREA	01/08/23
Amarin, Lotus Pharmaceuticals Agree to Exclusive Vazkepa Distribution Deal in 10 Asian Countries	31/07/23
Lotus Announces MFDS Approval for GRALISE SR, Once-Daily Tablets for Post-Herpetic Neuralgia	27/03/23
Lotus revenues grow by 16% and profit doubles year over year	13/03/23
Lotus acquires Alimta in Taiwan from Lilly	14/12/22
Lotus Pharmaceuticals - Aztiq and Innobic officially become Lotus's majority shareholders	12/07/22
Lotus Reports Solid Performance in First Quarter of 2022	16/05/22
Lotus Pharmaceuticals : Unaudited Financial Statement	30/03/22
Lotus Pharmaceuticals acquires Cialis (Tadalafil) in Taiwan from Lilly	23/03/22
Lotus achieves another record high EPS for FY2021	17/03/22
A powerful investment alliance of Aztiq and Innobic acquires Alvogen's shares in Lotus and Adalvo in a US$475m deal	29/11/21
Thai oil firm PTT expands pharma business with $475 million Alvogen deal	26/11/21
Lotus Pharmaceuticals : Informational Disclosure	22/11/21
Lotus Pharmaceuticals : Unaudited Financial Statements	22/11/21
Lotus Pharmaceuticals : Temasek-backed Vertex expects at least $400 million in new S.E.Asia/India fund	28/09/21
Lotus Pharmaceuticals : PTT invests in Lotus	19/04/21
LOTUS PHARMACEUTICALS, INC. : Other Events (form 8-K)	26/02/20

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Lotus Pharmaceuticals, Inc. Other OTC

Azioni

LTUS

US5457152032

Altre lingue

Filtri